Baxter Identifies Cybersecurity Incident Involving Third-Party Applications
The company reports no impact on manufacturing, patient services, or medical technology safety.
Tag: Baxter International
All
Latest
All
Latest
FDA Issues Early Alert on Baxter Spectrum Infusion Pump Recall
The FDA has issued an early alert regarding Baxter’s recall of certain Spectrum infusion pumps due to missing motor mounting screws, which may have occurred during servicing.
All
Latest
Baxter Finds Urgent Software Issue With Spectrum Infusion Pumps
Baxter announced an urgent issue with its Spectrum V8 and Spectrum IQ infusion pumps related to recent software updates.
All
Latest
Baxter Identifies Cybersecurity Incident Involving Third-Party Applications
The company reports no impact on manufacturing, patient services, or medical technology safety.
Baxter Issues Urgent Medical Device Correction for Home Care System
Baxter has issued an Urgent Medical Device Correction for the home care Volara System to reinforce important safety information.
Read More
FDA Upgrades Baxter Infusion Pump Safety Issue to Class I Recall
Baxter International has issued a Class I recall—the most serious type of recall—for its its Spectrum V8 and Spectrum IQ infusion pumps.
Read More
Baxter Warns of Missed Alarms with Some of Its Infusion Pumps
Baxter issued an urgent safety communication regarding the upstream occlusion alarms for its Spectrum V8 and Spectrum IQ infusion pumps.
Read More
Baxter Joins U.S. Cybersecurity and Infrastructure Security Agency Led Program
Baxter has joined government sponsored Common Vulnerabilities and Exposures program as a CVE Numbering Authority.
Read More
Baxter Officially Acquires Hillrom
Baxter announced in a release that it acquired Hillrom, which offers a portfolio of diagnostic, critical care, kidney care, hospital, and more.
Read More
Baxter to Buy Hill-Rom for $10.5 Billion After Prior Refusal
Baxter International Inc. is set to purchase Hill-Rom Holdings Inc. for $10.5 billion in cash. This came just a month after reports surfaced the initial offer had been rejected.
Read More
All
Latest
Baxter’s Preprogrammed Infusion Pump Software Recall Lands FDA Class 1 Label
Baxter has initiated a safety recall for its Spectrum Dose IQ Safety Software due to a potentially life-threatening defect in which incorrect drug-dosing information could be transmitted to the company’s Spectrum IQ Infusion System. The potential for patient harm is so serious, in fact, that the U.S. FDA has categorized it as a Class 1 recall.
